HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuexiang Du Selected Research

Interleukin-15 Receptors (Interleukin 15 Receptor)

12/2014Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8+ T cell responses.
11/2014Immunotherapy of metastatic and autochthonous liver cancer with IL-15/IL-15Rα fusion protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuexiang Du Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 06/2012
3Liver Neoplasms (Liver Cancer)
01/2019 - 11/2014
2Melanoma (Melanoma, Malignant)
01/2020 - 01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Breast Neoplasms (Breast Cancer)
05/2015
1Hepatocellular Carcinoma (Hepatoma)
12/2014

Drug/Important Bio-Agent (IBA)

6AntibodiesIBA
01/2022 - 01/2018
5Therapeutic UsesIBA
01/2022 - 06/2012
3IpilimumabIBA
01/2020 - 01/2018
2Monoclonal AntibodiesIBA
01/2020 - 04/2018
2Interleukin-15 (Interleukin 15)IBA
12/2014 - 11/2014
2Interleukin-15 Receptors (Interleukin 15 Receptor)IBA
12/2014 - 11/2014
2Proteins (Proteins, Gene)FDA Link
11/2014 - 06/2012
1EchinomycinIBA
01/2022
1Interleukin-2 (IL2)IBA
01/2019
1Fc Receptors (Fc Receptor)IBA
04/2018
1Antiviral Agents (Antivirals)IBA
01/2017
1interleukin-21 (interleukin 21)IBA
05/2015
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
12/2014
1Programmed Cell Death 1 ReceptorIBA
06/2012

Therapy/Procedure

8Therapeutics
01/2022 - 06/2012
8Immunotherapy
01/2022 - 11/2014
1Radiotherapy
06/2012
1Drug Therapy (Chemotherapy)
06/2012